article thumbnail

Nigerian e-health pharmaceutical distribution startup DrugStoc secures $4.4 million Series A funding, embarks on expansion drive

TechCrunch

The pharmaceutical supply chain across Africa has for decades remained fragmented leading to sourcing and distribution challenges as well as quality concerns; as fake and substandard products flood the market. Chibuzo Opara and Adham Yehia, the co-founders of DrugStoc, a tech-based pharmaceutical procurement platform.

article thumbnail

Hear how Cambrian BioPharma is reinventing drug (and drug company) development

TechCrunch

The startup Cambrian BioPharma is developing a life-changing technology while pioneering a radical approach to a pharmaceutical company. Cambrian BioPharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development. Register here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Balancing Innovation and Safety: The Tepezza Lawsuit’s Implications for the Pharmaceutical Industry

Strategy Driven

The mere onset of an unknown medical condition has the pharmaceutical giants leaving no stone unturned to deliver the antidotes as fast as they can. In this blog post, we will shed light on the concerns surrounding Tepezza and what it means for the ever-growing pharmaceutical industry.

article thumbnail

Hear how Cambrian BioPharma is reinventing drug (and drug company) development

TechCrunch

The startup Cambrian BioPharma is developing a life-changing technology while pioneering a radical approach to a pharmaceutical company. Cambrian BioPharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development. Register here.

article thumbnail

Hear how Cambrian BioPharma is reinventing drug (and drug company) development

TechCrunch

The startup Cambrian BioPharma is developing a life-changing technology while pioneering a radical approach to a pharmaceutical company. Cambrian BioPharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development. Register here.

article thumbnail

Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19

TechCrunch

According to a statement, the company will invest heavily in developing new manufacturing technologies across cell and gene therapies, viral vectors, vaccines and proteins. Founded by ARCH Venture Partners investor Robert Nelsen, National Resilience Inc., Flagship Pioneering raises $1.1

article thumbnail

Accelerating Aerospace Organizational Innovation, Speed, and Resilience with Digital Technologies

CIO

It is their ability to systematically innovate, push boundaries, and challenge norms that propels Aerospace every day — it is what excites growing countries and high-value entrepreneurs to invest. Companies are working with aerospace technologies to accelerate innovation and provide new differentiation.